These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 6852517)
1. [Treatment of chronic lympholeukemia patients with a combination of pafencil and cyclophosphane]. Iavorkovskiĭ LI; Grasmane DV; Iavorskiĭ LL; Zile MA; Sakson MP Gematol Transfuziol; 1983 Apr; 28(4):7-11. PubMed ID: 6852517 [No Abstract] [Full Text] [Related]
2. [Treatment of malignant lymphoma with Peptichemio. Preliminary communication]. Uszyński L; Maj S; Pawelski S Acta Haematol Pol; 1974; 5(2):153-7. PubMed ID: 4599294 [No Abstract] [Full Text] [Related]
3. An assessment of massive-dose chemotherapy of malignant disease. Bergsagel DE Can Med Assoc J; 1971 Jan; 104(1):31-6. PubMed ID: 4322068 [No Abstract] [Full Text] [Related]
4. [Direct results of using a new multimodal chemotherapy plan in malignant non-Hodgkin lymphomas]. Tolmacheva EL; Arkhipova NE; Tentsova IA; Chernova MK; Burova GF Sov Med; 1981; (6):82-3. PubMed ID: 7280804 [No Abstract] [Full Text] [Related]
5. [Polychemotherapy of multiple myeloma using pafencil (COPPaf protocol)]. Tsykalov VA; Zhuravlev VS; Mokeeva RA Gematol Transfuziol; 1989 Apr; 34(4):56-8. PubMed ID: 2744382 [No Abstract] [Full Text] [Related]
6. [Current tactics in the treatment of chronic lympholeukemia]. Faĭnshtein FE; Polianskaia AM; Kaloshina GA; Chernova MK; Enikeeva SM Probl Gematol Pereliv Krovi; 1971 Feb; 16(2):6-14. PubMed ID: 5573559 [No Abstract] [Full Text] [Related]
7. Complete remission in prolymphocytic leukaemia with the combination chemotherapy---CHOP. Sibbald R; Catovsky D Br J Haematol; 1979 Jul; 42(3):488-90. PubMed ID: 476003 [No Abstract] [Full Text] [Related]
12. Chemotherapy of sarcoma. A comparison of three regimens. Subramanian S; Wiltshaw E Lancet; 1978 Apr; 1(8066):683-6. PubMed ID: 76224 [TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy of advanced murine myeloma and subsequent resistance to tumor cell challenge. Teller MN; Bowie M; Mountain IM; Stock CC J Natl Cancer Inst; 1974 Mar; 52(3):667-71. PubMed ID: 4857022 [No Abstract] [Full Text] [Related]
14. Prolymphocytic leukemia: treatment with combination chemotherapy to include doxorubicin. Taylor HG; Butler WM; Rhoads J; Karcher DS; Detrick-Hooks B Cancer; 1982 Apr; 49(8):1524-9. PubMed ID: 6950800 [TBL] [Abstract][Full Text] [Related]
15. Wegener's granulomatosis: treatment with cytotoxic agents and adrenocorticoids. Raitt JW Ann Intern Med; 1971 Mar; 74(3):344-56. PubMed ID: 5552108 [No Abstract] [Full Text] [Related]
16. Tolerance to chemotherapy after prior irradiation for Hodgkin's disease. Curran RE; Johnson RE Ann Intern Med; 1970 Apr; 72(4):505-9. PubMed ID: 5437632 [No Abstract] [Full Text] [Related]
17. Phase I-II clinical trial with mitoclomine (NSC-114575) in chronic lymphocytic leukemia. Longeval E; Ganglji D; Stryckmans P; Kenis Y Cancer Chemother Rep; 1975; 59(6):1173-5. PubMed ID: 769961 [No Abstract] [Full Text] [Related]
18. [Changes of therapy results in acute leukemia under different treatment schedules with special reference to gnotobiotic measures]. Link H; Frauer HM; Wilms K; Waller HD Klin Wochenschr; 1983 Apr; 61(7):329-38. PubMed ID: 6575217 [No Abstract] [Full Text] [Related]
19. Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol). Haghbin M; Tan CC; Clarkson BD; Miké V; Burchenal JH; Murphy ML Cancer; 1974 Jun; 33(6):1491-8. PubMed ID: 4526012 [No Abstract] [Full Text] [Related]
20. Estramustine phosphate with multiple cytotoxic agents in treatment of advanced prostatic cancer. Beckley S; Wajsman Z; Maeso E; Pontes E; Murphy G Urology; 1981 Dec; 18(6):592-5. PubMed ID: 7198328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]